Related Experiment Video

Updated: Oct 2, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

Calpain inhibitor I and colonic inflammation induced by DNBS in the rat

A Ballinger, O Azooz

    Gut
    |February 13, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Investigating Intestinal Inflammation in DSS-induced Model of IBD
    08:43

    Investigating Intestinal Inflammation in DSS-induced Model of IBD

    Published on: February 1, 2012

    A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
    05:08

    A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

    Published on: March 1, 2022

    Related Experiment Videos

    Last Updated: Oct 2, 2026

    DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
    09:04

    DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

    Published on: February 27, 2014

    Investigating Intestinal Inflammation in DSS-induced Model of IBD
    08:43

    Investigating Intestinal Inflammation in DSS-induced Model of IBD

    Published on: February 1, 2012

    A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
    05:08

    A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

    Published on: March 1, 2022

    Related Concept Videos

    Inflammatory Bowel Disease II: Ulcerative Colitis01:20

    Inflammatory Bowel Disease II: Ulcerative Colitis

    Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

    Articles linked to this work by shared authors, journal, and citation graph.

    COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.

    Expert opinion on pharmacotherapy·2001

    Orlistat in the treatment of obesity.

    Expert opinion on pharmacotherapy·2001

    Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis.

    Gut·2000

    The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis.

    Gastroenterology·2000

    Plasma leptin in chronic inflammatory bowel disease and HIV: implications for the pathogenesis of anorexia and weight loss.

    Clinical science (London, England : 1979)·1998

    A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.

    Clinical cancer research : an official journal of the American Association for Cancer Research·1998

    Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts.

    Gut·2026

    Microbiota-host genetic interactions modulate MASLD risk in PNPLA3I148M carriers via ceramides and are reversible by targeted microbial interventions.

    Gut·2026

    Regulatory T cells in autoimmune liver diseases.

    Gut·2026

    Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.

    Gut·2026

    Rewinding the gut clock: from chronodisruption to targeted therapies.

    Gut·2026

    Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation.

    Gut·2026

    Senomorphic miR-3155b suppresses the senescence-associated secretory phenotype in therapy-induced senescence.

    Frontiers in cell and developmental biology·2026

    Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?

    Frontiers in pharmacology·2026

    Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents.

    Frontiers in oncology·2026

    Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies.

    Frontiers in immunology·2026

    Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies.

    Frontiers in immunology·2026

    Profiling crystal engineered ligands for targeting treatment resistant androgen receptors.

    Frontiers in pharmacology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us